January 17th 2024, 6:00pm
Whenever I experience a new ache or patch of itchy skin, I immediately think it's a health issue — or a recurrence.
December 11th 2023, 11:00pm
Researchers reported long-lasting responses and no new safety concerns in patients with relapsed/refractory follicular lymphoma during the 2023 ASH Annual Meeting and Exposition.
November 20th 2023, 11:00pm
Please don’t tell me I have the “good” kind of cancer or comment on how much weight I’ve lost.
October 15th 2023, 7:00pm
The Food and Drug Administration will speed up the review of odronextamab for patients with relasped or refractory follicular lymphoma or diffuse large B-cell lymphoma.
April 18th 2023, 7:00pm
One patient was able to access a therapy for follicular lymphoma before it was approved by the FDA, which allowed him to help future patients through his experience.
December 23rd 2022, 2:01pm
Patients with relapsed/refractory follicular lymphoma — a group that traditionally has limited treatment options — now have a new bispecific antibody available.
August 22nd 2022, 1:09pm
The combination treatment demonstrated survival and safety results similar to those of chemotherapy for patients with advanced, untreated follicular lymphoma.
July 8th 2022, 7:00pm
The FDA approval of Breyanzi, a novel CAR-T cell therapy, provides many patients with lymphoma a new treatment option that can be used earlier in the course of their disease, according to an expert.
July 7th 2022, 3:00pm
The priority review comes following positive clinical trial results, which may lead to a shift in the treatment paradigm for follicular lymphoma, according to an expert.
May 31st 2022, 1:59pm
Kymriah, a CAR-T cell therapy, was approved by the Food and Drug Administration for the treatment of patients with pretreated, relapsed/refractory follicular lymphoma.
Calquence Regimen Improves Outcomes in Frontline Mantle Cell Lymphoma
Cannabis May Help Chemo Nausea, Not a Substitute for Cancer Treatment
Embracing a New Way of Life After Cancer
Oncolytic Virus to Be Studied in Advanced Lung Cancer